Abstract
The scientific background to chelation therapy is reviewed. A review of the animal studies which have demonstrated that in animals treated with DTPA either a reduction in bone tumour incidence from internally deposited 239 Pu and 241 Am, or a significant increase in survival time may occur, suggests that it is reasonable to assume this could also occur in humans. The biokinetics and bioinorganic chemistry of cobalt, caesium, thorium, uranium, neptunium, plutonium and americium after their entry into the systemic circulation are reviewed briefly. These reviews discuss the general biokinetic behaviour of each element in adult humans with special reference to those aspects of their bioinorganic chemistry that either underlie existing approaches to decorporation therapy, or which might be exploitable for new types of treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
